Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TV-46000
TV-46000
Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III
BioSpace
Tue, 11/2/21 - 10:55 am
Teva Pharmaceutical
schizophrenia
clinical trials
Risperidone
TV-46000
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia
Pharmaceutical Business Review
Fri, 01/8/21 - 09:24 am
Teva Pharmaceutical
MedinCell
TV-46000
clinical trials
schizophrenia